In a recent opinion piece published in Dagens Medisin, Hanneke Rhodius-Meester, a senior researcher at the Memory Clinic of Oslo University Hospital and Amsterdam UMC as well as PROMINENT project partner, stressed that the necessary tools for improving dementia diagnosis are already here. While some suggest waiting for further technological advancements, such as AI-based solutions in development, Rhodius-Meester highlights that many advanced diagnostic tools are already being used in Europe. Examples include tools like NeuroQuant, which automatically analyses brain MRI scans and has been used for years in Norwegian clinics, as well as ADappt and cNeuro, which have been successfully implemented in memory clinics across Europe.
These tools predict the progression of dementia and differentiate between various types of the disease. cNeuro, in particular, has been integrated into global healthcare services and is now being implemented in Norway through the PROMINENT project. Rhodius-Meester emphasises that instead of waiting for new technologies, Norway should connect more closely with larger European research communities, leveraging existing solutions to address dementia now. This approach will not only avoid delays but also ensure that healthcare practices align with cutting-edge developments across Europe. The article is publicly accessible (in Norwegian), here: https://www.dagensmedisin.no/vi-trenger-ikke-vente-to-ar-pa-en-norsk-ki-losning/651190
